Zimmer Biomet Holdings(DE:ZIM)
€95.96+0.84 (+0.95%)
DE:ZIM
Zimmer Biomet Holdings stock forecast
€95.96
At close:+0.84 (+0.95%)
Zimmer Biomet Holdings (ZIM) Stock Forecast & Price Target
5 Followers
ZIM Analyst Ratings
Hold
4Buy13Hold0Sell
Based on 17 analysts giving stock ratings to Zimmer Biomet Holdings in the past 3 months
ZIM Stock 12 Month Forecast
Average Price Target
€103.35▲(7.71% Upside)Based on 17 Wall Street analysts offering 12 month price targets for Zimmer Biomet Holdings in the last 3 months. The average price target is EUR 103.35 with a high forecast of EUR 117.15 and a low forecast of EUR 87.41. The average price target represents a 7.71% change from the last price of EUR 95.96.
Past 12 Months12 Month ForecastJan2026Oct2026
High€117.15
Average€103.35
Low€87.41
Highest Price TargetHighest€117.15Average Price Target€103.35Lowest Price TargetLowest€87.41
Detailed List of Analyst Forecasts
Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
| Price Target | Article | |||||||
|---|---|---|---|---|---|---|---|---|
| Christopher Pasquale | Barclays | €90.12→€103.64 | hold | 8.00%Upside | Reiterated | 11/09/26 | ||
| Matthew O'Brien | Piper Sandler | €99.13 | hold | 3.30%Upside | Reiterated | 11/09/26 | ||
| Lee Hambright | Bernstein | €83.81→€96.43 | hold | 0.49%Upside | Assigned | 11/05/26 | ||
| Jeff Johnson | Robert W. Baird | €93.72→€102.73 | hold | 7.06%Upside | Reiterated | 11/05/26 | ||
| Larry Biegelsen | Wells Fargo | €92.82→€101.83 | hold | 6.12%Upside | Assigned | 11/05/26 | ||
| Rick Wise | Stifel Nicolaus | €99.13→€112.65 | buy | 17.39%Upside | Reiterated | 11/05/26 | ||
| Caitlin Cronin | Canaccord Genuity | €90.12→€100.03 | hold | 4.24%Upside | Reiterated | 11/05/26 | ||
| Patrick Wood | UBS | €108.14→€117.15 | buy | 22.09%Upside | Assigned | 11/05/26 | ||
| Robbie Marcus | J.P. Morgan | €105.44→€108.14 | hold | 12.69%Upside | Reiterated | 11/05/26 | ||
| Richard Newitter | Truist Financial | €95.53→€102.73 | hold | 7.06%Upside | Reiterated | 11/05/26 | ||
| Kendall Au | RBC Capital | €99.13→€112.65 | buy | 17.39%Upside | Reiterated | 11/04/26 | ||
| Joanne Wuensch | Citi | €89.22→€105.44 | hold | 9.88%Upside | Assigned | 11/04/26 | ||
| Ryan Zimmerman | BTIG | ― | hold | ― | Reiterated | 11/04/26 | ||
| Vik Chopra | BMO Capital | €86.51→€91.92 | hold | -4.21%Downside | Assigned | 11/04/26 | ||
| David Toung | Argus Research | €112.65 | buy | 17.39%Upside | Reiterated | 10/21/26 |
| Rating | Article | ||||
|---|---|---|---|---|---|
| Christopher PasqualeBarclays | HoldReiterated€90.12→€103.64 | 11/09/26 | 8.00%Upside | ||
| Matthew O'BrienPiper Sandler | HoldReiterated€99.13 | 11/09/26 | 3.30%Upside | ||
| Lee HambrightBernstein | HoldAssigned€83.81→€96.43 | 11/05/26 | 0.49%Upside | ||
| Jeff JohnsonRobert W. Baird | HoldReiterated€93.72→€102.73 | 11/05/26 | 7.06%Upside | ||
| Larry BiegelsenWells Fargo | HoldAssigned€92.82→€101.83 | 11/05/26 | 6.12%Upside | ||
| Rick WiseStifel Nicolaus | BuyReiterated€99.13→€112.65 | 11/05/26 | 17.39%Upside | ||
| Caitlin CroninCanaccord Genuity | HoldReiterated€90.12→€100.03 | 11/05/26 | 4.24%Upside | ||
| Patrick WoodUBS | BuyAssigned€108.14→€117.15 | 11/05/26 | 22.09%Upside | ||
| Robbie MarcusJ.P. Morgan | HoldReiterated€105.44→€108.14 | 11/05/26 | 12.69%Upside | ||
| Richard NewitterTruist Financial | HoldReiterated€95.53→€102.73 | 11/05/26 | 7.06%Upside | ||
| Kendall AuRBC Capital | BuyReiterated€99.13→€112.65 | 11/04/26 | 17.39%Upside | ||
| Joanne WuenschCiti | HoldAssigned€89.22→€105.44 | 11/04/26 | 9.88%Upside | ||
| Ryan ZimmermanBTIG | HoldReiterated | 11/04/26 | ― | ||
| Vik ChopraBMO Capital | HoldAssigned€86.51→€91.92 | 11/04/26 | -4.21%Downside | ||
| David ToungArgus Research | BuyReiterated€112.65 | 10/21/26 | 17.39%Upside |
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Best Analysts Covering Zimmer Biomet Holdings
3 Months
Success Rate6/11 ratings generated profit
55%
Average Return
-0.43%
Copying David Toung's trades and holding each position for 3 Months would result in 54.55% of your transactions generating a profit, with an average return of -0.43% per trade.
1 Year
Success Rate15/29 ratings generated profit
52%
Average Return
+4.49%
Copying Rick Wise's trades and holding each position for 1 Year would result in 51.72% of your transactions generating a profit, with an average return of +4.49% per trade.
2 Years
Success Rate6/13 ratings generated profit
46%
Average Return
+0.95%
Copying Vijay Kumar's trades and holding each position for 2 Years would result in 46.15% of your transactions generating a profit, with an average return of +0.95% per trade.
ZIM Analyst Recommendation Trends
| Rating | Jul 26 | Aug 26 | Sep 26 | Oct 26 | Nov 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 |
| Buy | 5 | 10 | 9 | 7 | 5 |
| Hold | 10 | 22 | 22 | 22 | 20 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 15 | 32 | 31 | 29 | 25 |
In the current month, ZIM has received 5 Buy Ratings, 20 Hold Ratings, and 0 Sell Ratings. ZIM average Analyst price target in the past 3 months is 103.35.
ZIM Financial Forecast
High€2.27
Consensus€2.23
Low€2.20
ZIM Earnings Forecast
Next quarter’s earnings estimate for ZIM is EUR 2.23 with a range of EUR 2.20 to EUR 2.27. The previous quarter’s EPS was EUR 1.70. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
High€2.06B
Consensus€2.05B
Low€2.03B
ZIM Sales Forecast
Next quarter’s sales forecast for ZIM is EUR 2.05B with a range of EUR 2.03B to EUR 2.06B. The previous quarter’s sales results were EUR 1.85B. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.
ZIM Stock Forecast FAQ
What is DE:ZIM’s average 12-month price target, according to analysts?
Based on analyst ratings, Zimmer Biomet Holdings’s 12-month average price target is €103.35.
What is DE:ZIM’s upside potential, based on the analysts’ average price target?
Zimmer Biomet Holdings has 7.71% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Zimmer Biomet Holdings a Buy, Sell or Hold?
Zimmer Biomet Holdings has a consensus rating of Hold, which is based on 4 buy ratings, 13 hold ratings and 0 sell ratings.
What is Zimmer Biomet Holdings’s share price target?
The average share price target for Zimmer Biomet Holdings is €103.35. This is based on 17 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is €117.15, and the lowest forecast is €87.41. The average share price target represents a 7.71% increase from the current price of €95.96.
What do analysts say about Zimmer Biomet Holdings?
Zimmer Biomet Holdings’s analyst rating consensus is a Hold. This is based on the ratings of 17 Wall Street analysts.
How can I buy shares of Zimmer Biomet Holdings?
To buy shares of DE:ZIM, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
